Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1CNS 1

Conditions

Breast Neoplasms 360Neoplasms 254Prostatic Neoplasms 206Colorectal Neoplasms 157Lung Neoplasms 136Carcinoma, Non-Small-Cell Lung 112Leukemia, Myeloid, Acute 109Pancreatic Neoplasms 99Multiple Myeloma 93Glioblastoma 80Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Brain Neoplasms 78Head and Neck Neoplasms 77Carcinoma, Hepatocellular 70Melanoma 68Squamous Cell Carcinoma of Head and Neck 66Uterine Cervical Neoplasms 61Ovarian Neoplasms 61Neoplasm Metastasis 59Rectal Neoplasms 53Hematologic Neoplasms 53Glioma 53Stomach Neoplasms 50Recurrence 49Carcinoma, Renal Cell 49Myelodysplastic Syndromes 47Sarcoma 46Motor Activity 46Triple Negative Breast Neoplasms 44Esophageal Neoplasms 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Parkinson Disease × 30 days × Clear all
NCT07595666 2026-05-19

Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.

Universitaire Ziekenhuizen KU Leuven

Phase NA Enrolling by invitation
1,600 enrolled
CNSEndocrineHead & Neck

Amyotrophic Lateral Sclerosis, Brain Neoplasms, Dementia, Epilepsy, Head and Neck Neoplasms, Movement Disorders, Neuroblastoma, Parathyroid Neoplasms, Parkinson Disease, Pituitary Neoplasms, Lewy Body Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡